Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$75.36 - $112.51 $2.61 Million - $3.89 Million
34,571 Added 159.56%
56,237 $4.5 Million
Q4 2023

Feb 09, 2024

BUY
$91.3 - $115.05 $493,020 - $621,270
5,400 Added 33.2%
21,666 $2.37 Million
Q3 2023

Nov 13, 2023

SELL
$97.55 - $135.91 $205,830 - $286,770
-2,110 Reduced 11.48%
16,266 $1.64 Million
Q2 2023

Aug 10, 2023

BUY
$102.55 - $136.38 $1.88 Million - $2.51 Million
18,376 New
18,376 $2.5 Million
Q4 2018

Feb 12, 2019

SELL
$57.41 - $79.06 $225,334 - $310,310
-3,925 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$73.09 - $81.64 $286,878 - $320,437
3,925 New
3,925 $311,000

Others Institutions Holding CNMD

About CONMED Corp


  • Ticker CNMD
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 30,482,400
  • Market Cap $2.14B
  • Description
  • CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for surgical procedures worldwide. It offers orthopedic surgery products, including TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and PopLok Knotless Suture Anchors, which provide uni...
More about CNMD
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.